Loss of pituitary hormone function after stereotactic radiosurgery for pituitary adenomas: mechanisms and management

• by Christina Abi Faraj, Ian E. McCutcheon

• June 6, 2026

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

• by Kathryn Wighton

• June 11, 2026

• 2 min

Glucagon-like peptide-1 receptor (GLP-1R) overexpression defines a distinct immunogenetic subset in primary and metastatic thyroid cancer: implications for GLP-1R agonist therapy

• by Sophia Kennedy, Jerin Thomas, Stella D’Arcy, Ivie Odia, Dev Kamdar, Lucio Pereira, Danielle Scarola, Brett Miles, Douglas Frank, Charit Taneja, Nagashree Seetharamu, Rajarsi Mandal

• May 28, 2026

Characteristics and risk factors of immune-related adverse events in patients receiving immune checkpoint inhibitor combination therapy

• by Yao Qiu, Xincai Zhao, Juan Chen, Manman Zhang, Yonggang Wang, Cheng Guo, Jianping Zhang, Rong Xu

• May 29, 2026